Acitrom Tablet, containing the active ingredient Acenocoumarol, is an oral anticoagulant widely used to prevent and manage blood clots in veins and arteries. By inhibiting vitamin K-dependent clotting factors, it reduces the risk of stroke, deep vein thrombosis (DVT), pulmonary embolism, and other thromboembolic disorders. For detailed medical guidance, trusted sources include Mayo Clinic, Drugs.com, and FDA.

Key Benefits & Uses:

• Prevents formation of harmful blood clots

• Reduces risk of stroke in patients with atrial fibrillation

• Treats and manages deep vein thrombosis (DVT) and pulmonary embolism

• Maintains proper blood circulation and cardiovascular health
  For more insights on anticoagulants, see WebMD, Healthline, and PubMed.

How to Use:
Acitrom Tablet should be taken exactly as prescribed by your healthcare provider. Usually administered once daily, preferably at the same time each day. Regular blood tests (INR monitoring) are recommended to ensure effective dosing. Avoid self-adjusting the dose. Comprehensive dosage guidelines are available at FDA and Mayo Clinic.

Important Safety Information:

• Inform your doctor about any liver, kidney, or bleeding disorders.

• Avoid alcohol and medications that can increase bleeding risk.

• Monitor for unusual bruising, bleeding gums, or prolonged bleeding.

• Pregnant or breastfeeding patients should consult their doctor before use.

• For further safety tips, visit WHO and Drugs.com.

Common Side Effects:

• Minor bleeding or bruising

• Nausea or vomiting

• Fatigue or dizziness

• Rarely, severe bleeding may occur
  Consult a healthcare provider immediately if severe symptoms appear. More information on side effects is available at WebMD and Healthline.

Why Choose Acitrom Tablet:
Acitrom Tablet (Acenocoumarol) is a trusted anticoagulant that offers reliable clot prevention and cardiovascular protection. With consistent monitoring and adherence to prescribed dosages, patients can effectively reduce their risk of thromboembolic complications. Trusted sources like PubMed, FDA, and WHO highlight its clinical benefits and global acceptance.